India welcomes pioneering Parkinson's treatments

Representational Image

India has begun a new, promising era in Parkinson's disease treatment, as new therapies and scientific advances now start to transform the way the condition is treated. From the availability of drug therapies recognised across the world to indigenous research being developed, the country's patients now have better options and more hope of improving their lifestyle, the Times of India reported.

A revolutionary drug finally arrives on Indian shores

Apomorphine, which is a drug widely used in the West to control Parkinson's, is now possible in India with injectables or through pumps. The therapy alleviates motor symptoms rapidly and benefits patients most with whose disease responds poorly to routine oral medication.

India's Drug Controller General recently approved its use, with Hyderabad-based Celera Pharma joining hands with a German company, EVER Neuro Pharma, to make the treatment available in Indian hospitals and clinics. Patients can be administered apomorphine either through pen-like injectors or through a pump system that provides a steady supply of the drug.

Physicians estimate that some 40% of Parkinson's patients in the nation might be helped by these device-assisted treatments. Up to now, choices for patients in advanced stages of the disease were few — this may be a significant change in standards of care.

Indian scientists investigate a possible cure

As new therapies provide relief, scientists across India work tirelessly in pursuit of a lasting answer. At Chandigarh's Institute of Microbial Technology (IMTECH), scientists collaborating with Danish researchers have found a substance that seemed to halt disease in mice in lab tests. While preliminary, the results are being touted as a big breakthrough.

At the same time, scientists at Delhi University have developed a molecule that aids in preserving the dopamine-producing neurons damaged in Parkinson's disease. By keeping dopamine levels steady in the brain and protecting cells from premature death, this molecule might eventually become an important tool in preventing or slowing the condition — provided clinical trials are successful.

These studies are still several years from being used in the real world, but they indicate increasing scientific momentum in India.

More than medicine: why a wider approach is needed

Experts emphasize that Parkinson's can be effectively managed by more than just medication. Most neurologists advise a mix of medication, exercise on a regular basis, diet plans suited to individual needs, and in advanced stages, surgical procedures like Deep Brain Stimulation (DBS).

DBS entails the implantation of electrodes in certain areas of the brain to enhance movement control. Though expensive and not without danger, it has restored independence to many patients. Physical therapy and speech therapy also have important roles, particularly in assisting with symptom management such as balance issues and speaking difficulties.

A promising road ahead

With the introduction of apomorphine injections and a swelling tide of new research, India's strategy for Parkinson's disease is poised for a new dawn. Not only symptom relief do these developments portend, but also hope — hope that someday Parkinson's may be a disease we know more about, treat sooner, and possibly even cure.